GSK has reported much-needed progress with two of its cancer therapies, with a phase 3 trial win for immunotherapy Jemperli in endometrial cancer and the start of a review in the EU for myelofibrosis ...
My days of chronicling sleazy sports-related trials peaked six years ago, when I won the Pulitzer Prize for my "Idiot's Guide to the Gold Club Trial" column. That one will never be topped. We had a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback